Par Health Issues Voluntary Nationwide Recall Of Two Lots Of Brevital® Sodium 500 Mg/vial Civ (methohexital Sodium For Injection, Usp) Due To The Presence Of Particulate Matter
Par Health is recalling two lots of Brevital® Sodium 500 mg/vial, an injectable anesthetic medication, because cellulose particles were found in the product. The recall affects hospital supplies of this drug. The recall is being conducted at the hospital level.
- Recalling firm
- Par Health
- Product
- Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium
- Reason
- FOR IMMEDIATE RELEASE - ROCHESTER, MI– October 8, 2026 –Par Health is voluntarily recalling two lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose.
- Category
- drug recall
- Country
- United States
- Agency
- FDA-MEDWATCH-RSS
- Recall date
- 2026-10-09
- Status
- Ongoing
Official recall notice from FDA-MEDWATCH-RSS
Recall details on Nibble Recalls: https://trynibble.app/recalls/0f07c1a6-5301-437c-95a6-34365fe7f83d